about
An indirect enzyme-linked immunosorbent assay for rapid and quantitative assessment of Type III virulence phenotypes of Pseudomonas aeruginosa isolates.Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virusCrystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface EpitopesAntiviral Peptides Targeting the West Nile Virus Envelope ProteinSerum antibodies to West Nile virus in naturally exposed and vaccinated horsesA recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cellsCrystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane FusionInflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacyA Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF)Structural and biochemical analyses of alanine racemase from the multidrug-resistantClostridium difficilestrain 630Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay.Swarming motility, secretion of type 3 effectors and biofilm formation phenotypes exhibited within a large cohort of Pseudomonas aeruginosa clinical isolatesAnalysis of β-cell death in type 1 diabetes by droplet digital PCR.The ability of virulence factor expression by Pseudomonas aeruginosa to predict clinical disease in hospitalized patientsInhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinonesβ cell death and dysfunction during type 1 diabetes development in at-risk individuals.Efficient Detection of Pathogenic Leptospires Using 16S Ribosomal RNADiscovery and pre-clinical development of antithrombotics from hematophagous invertebrates.Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus.Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody.Characterization of Ixophilin, a thrombin inhibitor from the gut of Ixodes scapularisTLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.Detection of antibodies to West Nile virus in equine sera using microsphere immunoassay.Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice.A recombinant envelope protein vaccine against West Nile virus.Coordination of different ligands to copper(II) and cobalt(III) metal centers enhances Zika virus and dengue virus loads in both arthropod cells and human keratinocytes.West Nile virus envelope protein inhibits dsRNA-induced innate immune responses.
P50
Q25256862-D5A70799-FFBE-4F47-B9A5-75A0E6283ED7Q27472711-2698B891-FF0F-4981-979C-261C3598B897Q27477610-6664C4CE-F035-42C4-8DAB-3C746977AE95Q27478055-85981DA9-E364-4B7B-B318-1EC903CED8FFQ27487014-2DD83681-1451-44D0-99D1-0ACD4A86405AQ27487992-568B8C95-A9C8-41FA-84ED-726155E0E288Q27488305-813BA84F-E8D2-4B09-BD78-56C8D7025A4BQ27488746-64277344-AEAE-47DF-9A06-1F782414C7C8Q27670700-1A794D0E-AD8F-4E04-84A0-BCC36C9136F6Q27684595-84CDB724-7174-46F2-8189-C934FE66AD3DQ30827379-4D066FA7-14F7-4F4A-882E-DF42A2D757D9Q33792561-27210963-A5BB-43E1-9082-E695305568E4Q34068302-1B9845E2-302E-4046-A892-8F41F71DB7E7Q34478058-984F0A14-CE45-4D93-9F24-49B199D27C50Q34726267-491F6169-072A-4FEE-904F-5AED3A6D51CAQ35183950-1932CDFE-57B3-4C5A-9FFE-6372AF080D4CQ35668848-17D8B677-1E39-4EBF-8DF0-8F29D51D5319Q36002791-943E5444-1FA8-423E-8EF4-D281165A424CQ36339669-7F75BF63-49C5-41C2-B754-F6F03BEC3D1EQ36950014-AECCE245-D3D6-46B6-A719-38710AE0E863Q36997428-99557FA9-59A1-420B-B048-2FE90D9657B3Q37120117-B93142BD-3BF9-4A0C-881F-82545F55B731Q40429707-B4B1D548-9B16-41C3-A9B0-7B2F8F3422D6Q40471912-4F690798-BCC1-46C1-A105-C14DEF52A74CQ40474329-B95AC1AD-8C14-448C-B40A-D4BA8C3176F8Q40507551-85868C90-F34F-42DB-893C-2ECE4667064EQ43047482-1EAD1104-7727-484B-9955-D47681750A42Q43048374-D0713727-A9B7-440D-B281-5324C608C7D0
P50
description
onderzoeker
@nl
name
Michel Ledizet
@ast
Michel Ledizet
@en
Michel Ledizet
@es
Michel Ledizet
@nl
Michel Ledizet
@sl
type
label
Michel Ledizet
@ast
Michel Ledizet
@en
Michel Ledizet
@es
Michel Ledizet
@nl
Michel Ledizet
@sl
prefLabel
Michel Ledizet
@ast
Michel Ledizet
@en
Michel Ledizet
@es
Michel Ledizet
@nl
Michel Ledizet
@sl
P106
P21
P31
P569
2000-01-01T00:00:00Z